Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07774403 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07774403 · ClinicalTrials.gov record · last posted 2026-08-19

A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Name: A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization — clinical trial record (NCT07774403)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BREEZE

StatusRecruiting

PhasePhase 2

SponsorAstraZeneca

Started2026-06-24

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.

Trial Details

NCT Number	NCT07774403
Lead Sponsor	AstraZeneca
Conditions	Bronchiectasis With Pseudomonas Aeruginosa Colonization
Enrollment	84 participants
Start Date	2026-06-24
Primary Completion	2028-01-18 (estimated)
Study Completion	2028-06-06 (estimated)
Updated on ClinicalTrials.gov	2026-08-19